Content area

|
|

Behandling af svær aktiv morbus Crohn med adalimumab

Forfatter(e)
Reservelæge Ulrich Christian Bang & overlæge Anette Mertz Nielsen Hvidovre Hospital, Gastroenheden
Reference: 
Ugeskr Læger 2008;170(25):2256
Blad nummer: 
Sidetal: 
2256
Summary The use of adalimumab in severe fistulising Crohn's disease - three cases Ugeskr Læger 2008;170(25):2256 So far infliximab is the only approved anti-TNF-α antibody for patients with Crohn's disease. Development of antibodies to infliximab may result in allergic reactions or reduced effect. We report three patients who received adalimumab, which induced longstanding remission in all three patients.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Sven Refslund Poulsen | 25/01
1 Kommentar
af Camilla Lund Borch | 25/01
1 Kommentar
af Bolette Gerd Friderichsen | 25/01
5 kommentarer
af Frederik Winsløw | 22/01
2 kommentarer
af Helle Borgstrøm | 22/01
10 kommentarer
af Martin Lindhardt Nielsen | 22/01
1 Kommentar
af Kurt Håkonsson | 19/01
4 kommentarer